Henry Schein, Inc.
Henry Schein, Inc. (HSIC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HSIC · as of Jun 8, 2026
Key Statistics
Explore Henry Schein, Inc. Data
hsic stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 32 · Buy rate: 43.8%
The HSIC analyst consensus is Hold, based on ratings from 32 Wall Street analysts over the past 3 months. The average 12-month price target is $85.43, representing +10.30% upside from the current price of $77.45.
Competitors & Peers
hsic competitorsHSIC
ATR
AVTR
BIO
DVA
GMEDStock Performance
Full HistoryAbout Henry Schein, Inc.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care cli…
what is henry schein, inc. · hsic stock overview · henry schein, inc. company profile · who is henry schein, inc. ceo · hsic NASDAQ · henry schein, inc. headquarters · henry schein, inc. business segments
About Stock Overview & Key Data
Henry Schein, Inc. (HSIC) is a Healthcare company in the Medical - Distribution industry, listed on NASDAQ since Nov 3, 1995. As of the latest trading session, HSIC stock price is $77.45, with a market capitalization of $8.8B. The stock has returned +9.24% over the past 12 months and +2.47% year-to-date.
According to 32 Wall Street analysts, the consensus rating for Henry Schein, Inc. stock is Hold, with an average 12-month price target of $85.43. In fiscal year 2025, Henry Schein, Inc. reported revenue of $13.2B and net income of $398.0M. For detailed data — including Henry Schein, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Henry Schein, Inc. (HSIC) stock price is $77.45. The stock is traded on NASDAQ under the ticker symbol HSIC. The 52-week range is $61.95 – $89.29.